Mostrar el registro sencillo del ítem

dc.contributor.authorBrito Zeron, Pilar
dc.contributor.authorAkasbi, Miriam
dc.contributor.authorBosch, Xavier
dc.contributor.authorBove, Albert
dc.contributor.authorPerez de Lis, Marta
dc.contributor.authorDiaz Lagares, Candido
dc.contributor.authorRetamozo, Soledad
dc.contributor.authorGandia, Miriam
dc.contributor.authorPérez Alvarez, Roberto
dc.contributor.authorSoto Cardenas, María José 
dc.contributor.authorSiso, Antoni
dc.contributor.authorValls-Sole, Josep
dc.contributor.authorGraus, Francesc
dc.contributor.authorRamos-Casals, Manuel
dc.contributor.otherCirugíaes_ES
dc.contributor.otherMedicinaes_ES
dc.date.accessioned2026-04-08T12:17:38Z
dc.date.available2026-04-08T12:17:38Z
dc.date.issued2013
dc.identifier.issn1593-098X
dc.identifier.urihttp://hdl.handle.net/10498/39227
dc.description.abstractObjectives: This paper aims to analyse the etiology, characterisation and outcomes of the different types of peripheral neuropathy in patients with primary Sjögren's syndrome (SS) and their association with clinical and immunological disease expression. Methods: A total of 563 consecutive patients diagnosed with primary SS were evaluated. We retrospectively assessed the results of nerve conduction studies carried out in patients with suspected peripheral nervous system involvement. Peripheral neuropathies were classified into mononeuropathy, mononeuropathy multiplex, polyneuropathy and neuronopathy according to the patterns evidenced by electrodiagnostic studies. Results: Nerve conduction studies were carried out in 158/563 (28%) SS patients. The results were normal in 49 and abnormal in 109 patients, in whom peripheral neuropathy was diagnosed in 102. After excluding patients with neuropathy associated with other diseases and patients with entrapment mononeuropathies, 55/563 (10%) patients were classified as having SS-related peripheral neuropathy, including axonal sensorimotor polyneuropathy (n=24), pure sensory neuronopathy (n=15), mononeuropathy multiplex (n=15) and demyelinating polyradiculoneuropathy (n=1). In spite of therapy, clinical progression measured by the MOHS scale was observed in 12% of patients with axonal polyneuropathy, 13% of those with mononeuropathy multiplex and 47% of those with neuronopathy. Survival was significantly reduced in patients with peripheral neuropathy (especially in those with mononeuropathy multiplex and axonal polyneuropathy) in comparison with the control group (log rank =0.001). Conclusions: We found a prevalence of SS-related peripheral neuropathy of 10%. Classification of neuropathy according to the clinical presentation and electrodiagnostic tests may be useful in determining the functional outcome, therapeutic response and survival.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherClinical and Experimental Rheumatologyes_ES
dc.sourceClinical and Experimental Rheumatology - 2013, vol. 31, nº 1, pp. 103-110es_ES
dc.subjectprimary Sjögren’s syndromees_ES
dc.subjectperipheral neuropathyes_ES
dc.subjectneuronopathyes_ES
dc.subjectvasculitises_ES
dc.subjectfocal nerve entrapmentes_ES
dc.titleClassification and characterisation of peripheral neuropathies in 102 patients with primary Sjögren's syndromees_ES
dc.typejournal articlees_ES
dc.identifier.urlhttps://www.clinexprheumatol.org/abstract.asp?a=5938
dc.rights.accessRightsopen accesses_ES
dc.type.hasVersionVoRes_ES


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem